Microfluidic platform for the enzymatic pretreatment of human serum for the detection of the tuberculosis biomarker mannose-capped lipoarabinomannan-Reference-Cited by-同舟云学术

Microfluidic platform for the enzymatic pretreatment of human serum for the detection of the tuberculosis biomarker mannose-capped lipoarabinomannan

Published:2024 Issue:31 Volume:16 Page:5475-5481
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Lambert Christopher J.¹^ORCID,Clarke Eamonn²^ORCID,Patel Dhruv¹^ORCID,Laurentius Lars B.³^ORCID,Gale Bruce K.¹^ORCID,Sant Himanshu J.¹^ORCID,Porter Marc D.²⁴^ORCID

Affiliation:

1. Departments of Mechanical Engineering, University of Utah, Salt Lake City, UT, 84112, USA

2. Chemistry, University of Utah, Salt Lake City, UT, 84112, USA

3. Electrical and Computer Engineering, University of Utah, Salt Lake City, UT, 84112, USA

4. Chemical Engineering, University of Utah, Salt Lake City, UT, 84112, USA

Abstract

This study demonstrates the ability to enzymatically pretreat human serum samples for quantitative recovery of the TB marker mannose-capped lipoarabinomannan by a microfluidics device for ELISA detection.

Funder

Small Business Innovative Research and Small Business Technology Transfer

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/AY/D4AY00772G

Reference50 articles.

1. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?

2. Recent technological advancements in tuberculosis diagnostics – A review

3. Point-of-care diagnosis of tuberculosis: Past, present and future

4. World Health Organization , Global Tuberculosis Report 2023 , Geneva , 2023

5. Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review